CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing Post author: Post published:December 4, 2023 Post category:uncategorized CN Bio today announced its PhysioMimix® assay for Non-alcoholic steatohepatitis (NASH). You Might Also Like Polytherapy improves blood pressure control and survival in metastatic breast cancer February 26, 2026 Study reveals brain mechanisms behind post-stroke urinary incontinence April 13, 2026 What would a Desantis presidency look like for health care? November 24, 2023
Polytherapy improves blood pressure control and survival in metastatic breast cancer February 26, 2026